Core Viewpoint - AngioDynamics, Inc. is expected to report a quarterly loss of 12 cents per share for Q1, with projected revenue of $72.69 million, indicating growth compared to the previous year [1] Group 1: Earnings Expectations - The company will release its earnings results for the first quarter on October 2 [1] - Analysts predict a quarterly loss of 12 cents per share, compared to a loss of 11 cents per share in the same period last year [1] - Projected quarterly revenue is $72.69 million, up from $67.49 million a year earlier [1] Group 2: Recent Performance and Analyst Ratings - On July 15, AngioDynamics reported better-than-expected fourth-quarter results and provided FY26 revenue guidance above estimates [2] - Following the positive report, shares rose by 4% to close at $11.17 [2] - HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 for July 16, 2025 [4] - Canaccord Genuity analyst William Plovanic maintained a Buy rating and increased the price target from $15 to $17 for July 16, 2025 [4]
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - AngioDynamics (NASDAQ:ANGO)